Icon PLC (FRA:IJF)
€ 202.9 -3.3 (-1.6%) Market Cap: 16.44 Bil Enterprise Value: 19.11 Bil PE Ratio: 23.96 PB Ratio: 1.82 GF Score: 96/100

ICON PLC at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 05:40PM GMT
Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

All right. Good morning, everyone. Welcome to the ICON session. I'm Bob Jones, and I cover the CRO industry here at Goldman Sachs. Very pleased to have ICON, a leading clinical CRO up on stage with us today. Representing the company, I'm joined by Dr. Steve Cutler, who has been CEO of ICON since March of 2017, previously had been the COO from January 2014, prior to this, he served as the Group President of Clinical Research Services, I believe, since 2011. So definitely, has been with the company for a number of years now and really excited to have him with us.

The format, I think, by this point, everyone is aware to the extent that you have a question, please feel free to raise your hand and we'll be sure to get you a microphone.

Questions & Answers

Robert Patrick Jones
Goldman Sachs Group Inc., Research Division - VP

I guess, Dr. Cutler, just to start, over the past 2 to 3 years, it seems like a lot of the larger, global CROs have made an attempt mainly through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot